SERPINE1 and obesity disorder: It is well known that PAI-1 is an efficient inhibitor of fibrinolysis and its augmentation has been linked to a variety of clinical conditions including obesity, insulin resistance, psychosocial stress, reduced immune responses, increased inflammation and thrombotic events (Cesari et al., 2010).